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Dermal Fillers
The solution for lines, wrinkles, lip enhancement
and facial contouring.
Keywords: dermal fillers, tissue augmentation, hyaluronic acid, collagen replacement
therapy, polymethylmethacrylate (PMMA) microspheres .
Tissue augmentation is a specialist area of bio-engineering
which has been the subject of intrinsic research over the
last twenty-five years, and represents a marriage of
innovative pharmacology and chemical applications as
diverse as reconstructive surgery, cosmetology, ophthalmic/
ENT and orthopaedics.  In the field of cosmetic surgery,
dermal filling is one of the most performed procedures.
The earliest skin tissue expander or filler was autologous-
fat which is today undergoing a revival, as extraction and
injection methods improve.
The greatest research and successes,
however, relate to connective tissue
matrix material mainly collagen and
hyaluronic acid, derived from non-
human sources. Synthetic or semi-
synthetic materials, notably
polymethylmethacrylate (PMMA), gore-
tex and, more debatably, silicone, also
have a niche application.  These latter
products are marked by superior
persistence and longevity in the body
but carry attendant risks of
complications, notably rejection,
granuloma formation and scarring.
This article seeks to present a
balanced review of the state of the art
of some of the most commonly used
fillers, namely, the two temporary
fillers, namely bovine collagens  and
avian hyaluronic acid (HA), and the
semi-synthetic semi-permanent filler
PMMA - Collagen .  The chemical
properties, clinical applications and
cautionary features of each product are
described.
polysaccharide is the same throughout
nature. This property has enormous
benefits with respect to immunological
compatability. Until recently, the most
successful dermal soft tissue implants
have been derived from bovine collagen
whose use, because of species and
tissue specificity, may be impeded by
clinical reactions due to immunological
incompatibility. The concept of using a
hyaluronan derivative - hylan B gel
(produced by a bis-ethyl-sulfonyl-
crosslinking  process that links every
hyaluronic acid molecule into a
continuous cross-linked polymer
network such that the individual
molecules are no longer freely soluble)1
- for soft tissue augmentation was
developed by Balazs and co-workers as
a result of years of research. They
established that insoluble, injectable,
cross-linked hylan gels made from
hyluronan exhibited a prolonged
residence time in soft tissues and were
as biocompatible as natural hyaluronan.
HA is injected into the dermal
tissue to provide a space-occupying
viscoelastic supplement for the
intercellular matrix of the connective
tissue. This viscosupplementation or
augmentation of the dermal tissue can
result in the correction of skin contour
deficiencies caused by wrinkles and
depressed scars.
Indications for using HA
• Nasolabial folds - the lines
extending in an arc from the corners
of the mouth to each outside edge
of the nose.
• Oral commissures (Marionette Lines)
- the lines extending down from the
corners of the mouth to the jaw.
Figure 1: Hylan B gel Molecule (reproduced, with permission,
from Piacquadio et al, 1998).1
1  Hyaluronic acid (HA)
It is perhaps, the extradinary
biocompatibility of the hyaluronan
molecule that distinguishes it so
markedly from other classes of
materials used in soft tissue
augmentation. Hyaluronan exhibits no
species or tissue specificity because the
chemical structure of this
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any acute or chronic skin disease in or
near the intended area of correction.4
Cautions
Hylan B must not be injected into
blood vessels. It may occlude the
vessels, and could cause infarction or
embolization.
2  Collagen
Collagen - which means glue in
Greek - is a naturally occurring protein
found in all mammals.  It provides
structural support for the bones, skin,
tendons, ligaments, blood vessels, and
almost every internal organ.  Collagen
has been used as a biomaterial in
medicine and surgery for almost a
century in sutures, haemostatic agents,
wound dressing and heart valve
replacement.
Structure And Chemical
Composition
The strength and resilience of
collagen is derived from the
arrangement of the molecule, a rigid,
triple-stranded helical structure,
consisting of three polypeptide chains
of 1000 amino acids wound around
each other in a regular helical
configuration. At both ends of the
helical structure, there are short non-
helical amino acid sequences known as
telopeptides.
Bovine Collagen
Bovine collagen is derived from the
hide of cows and is very similar in
chemical composition to human
collagen.  The telopeptides are the
regions of greatest chemical variability
from species to species and
consequently these sites are most likely
to elicit an immune response when
implanted in a foreign host. To reduce
Figure 2: Tunnelling injection technique
using HA (reproduced, with permission,
from Piacquadio et al, 1998).1
Figure 3: Lip Augmentation using
Hylan B (reproduced, with permission,
from Balazs and Leshchiner, 1989).3
Figure 4: Similarity between human
and bovine derivative (reproduced,
with permission, from Balazs 1991).5
the risk of an immune response the
telopeptides are removed from the
bovine collagen using a protease
enzyme, pepsin.
Collagen is licensed as a medical
device to correct lines, wrinkles or
scars.  The practitioner injects small
amounts of collagen directly into the
dermis where the body’s own collagen
has been weakened by disease, trauma,
atrophy, or age.  The treatment restores
the contour of the skin, minimising
lines and wrinkles, and is often referred
to as collagen replacement therapy.
Composition
Collagen is composed of highly
purified sterile bovine collagen
suspended in saline and 0.3% of the
local anaesthetic lignocaine.
Collagen Replacement Therapy
As collagen is a naturally occurring
product, it is metabolised over time.  In
70% of patients the treatment has to
be repeated every six to twelve months.
However, 30% of patients maintain full
correction for up to 12 months.  For
some patients this can be perceived as
an advantage, as they do not have to
commit to a surgical procedure that is
permanent.  Unlike surgery, the
recovery time after collagen
replacement therapy ranges from a few
hours to a few days with minimal side-
effects.5
Benefits of collagen
Collagen offers the following
benefits:
• It is a simple and relatively painless
procedure
• Results are almost immediate
compared to other methods of skin
rejuvenation and dermal correction
techniques
• Glabellar furrows (Frown Lines) - the
vertical lines directly above the top
of the nose and in between the
eyebrows.
• Lip border - the border around the
lips
• Peri-orbital - lines at the corner of
the eyes
• Peri- oral - lines on the top of the
upper lip.2
Depending on type of skin and
lesion, best results are obtained in
areas where these defects are readily
distensible and where the correction
can be visualised by manual
manipulation (stretching) of the skin.
Injection procedure.
The patient has to sit upright for
injection. Gravity will let the skin fall
naturally so that the doctor can
identify and treat the appropriate lines.
The skin is stretched to provide a firm
surface for injection. When injecting,
the defect should not be over
corrected; it should be raised to the
desired level of correction. For fine
wrinkles and scars it is best to place
the filler in the papillary dermis. For
deeper lines, the material is best placed
in the reticular dermis. This can be
followed by a more superficial injection
into the papillary dermis to complete
the treatment if needed.
For lip augmentation, the material
should be injected into the apparent
space between the body of the lip and
the dermis of the upper lip (vermillon
border) to create fuller lips (Figure 3).
Contraindications
Hylan B is contraindicated for breast
augmentation, for implantation into
bone, tendons, ligament or muscle. It
must not be injected in patients with
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hydrochloride. The collagen serves as a
vehicle for injection and is eventually
degraded, leaving behind permanent
implantation of the beads. All
microspheres will be totally and evenly
encapsulated by a fine fibrous capsule
with minimal inflammatory reaction.7
Since the PMMA microspheres are non-
biodegradable, and too large to be
phagocytosed or to migrate, the
resulting tissue augmentation will be
long lasting, if not permanent. Patients
must be tested for allergy to bovine
collagen prior to administration. Before
using this filler, a skin test is optimally
carried out 14 to 21 days prior to
injection to determine the sensitivity
for bovine collagen.
Injection Technique
The mixture is injected without
overcorrection subdermally, that is, into
the border of dermis to subcutaneous
fat to treat deeper rhytids and scars.
While injecting the needle should be
drawn forwards and backwards
(tunnelling technique) while
maintaining constant pressure
throughout the procedure, filling the
channels thus created with the filler.8
The injection pressure is correct if the
implant flows slowly but evenly and
without great exertion. The gray of the
needle should never shine through the
skin,
Contraindications and cautions
Contraindications to using this filler
include sensitivity to bovine collagen, a
history of keloids or atrophic skin
diseases and patients with thin, flaccid
skin because of the risk of permanent
surface irregularities.9
The Future of Dermal Fillers
From the above, it would appear
that the ideal dermal filler should:
• Be chemically and immunologically
inert
• Have a space occupying effect
lasting between 1-5 years, beyond
which body contours are likely to
alter as part of the aging process,
so that the expander effect becomes
less desirable
• Be easy to administer with minimal
local tissue trauma
The industry is already perfecting
its search for the above fillers and the
most recent offerings are tissue
expanders of human origin, either
cadaveric or bio-engineered.  Human
collagen has recently obtained FDA
approval and has entered clinical use
this year.
Figure 5: PMMA molecule (reproduced,
with permission, from Klein, 1992).7
• It is associated with a low incidence
of adverse reactions provided the
recommended screening procedures
are followed
• There is a high level of patient
satisfaction with the aesthetic
result
Indications for collagen
replacement therapy
Collagen can be used to correct a
range of facial deficiencies ranging from
fine lines to deep scars and furrows.
Collagen replacement therapy can also
be used in combination with other
treatments, such as topical retinoids,
chemical peels and facial surgery and
will produce excellent results.6
Hypersensitivity
Hypersensitivity is by far the most
common adverse reaction to collagen
replacement therapy, occurring in
approximately three per cent of
patients undergoing a test implant.  A
hypersensitivity reaction is
characterised by erythematous,
oedematous pruritic areas limited to
the site of injection.6
Complications
These include:
• Cyst and abscess formation
• Necrosis
• Autoimmune diseases.
3 Homogenous
non-biodegradable
polymethylmethacrylate
(PMMA) microspheres filler
Composition and mode of action
This filler is suspended in 3.5%
bovine collagen and an average
concentration of 0.3% lidocaine
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